2m 2m 2m 2m 2m 2m 2m
Cerus (CERS)
NASDAQ
$3.21+$0.12 (+3.92%)
Price as of Jul 14, 2026 8:05 AM EDT- $619.1MMarket Cap
- 113.10%1-Year Change
- Medical DevicesIndustry
Cerus (CERS)
$3.21+$0.12 (+3.92%)
CERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.09 | ||
Change | -$0.03 (-0.96%) | ||
Open | $3.08 | ||
High | $3.15 | ||
Low | $3.03 | ||
Previous Close | $3.12 | ||
Volume | 1,192,917 | ||
30-Day Average Volume | 2,941,799 | ||
1-Week Change | -5.79% | ||
1-Month Change | 20.70% | ||
1-Year Change | 113.10% | ||
3-Year Change | 22.13% | ||
5-Year Change | -38.81% | ||
Fundamentals | |||
Shares Outstanding | 200.4M | ||
Total Assets | $222.9M | ||
Market Cap | $619.1M | ||
Enterprise Value | $676.1M | ||
Period: QTR TTM FY | |||
Revenue | $53.7M | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$3.3M | ||
EBIT | -$1.5M | ||
EBITDA | -$1.1M | ||
Net Working Capital | $68.0M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -614 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 9 | ||
P/E | -309 | ||
PEG | -25 | ||
Price/Free Cash Flow | -189 | ||
Price/Operating Cash Flow | -203 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue